KLF16 promotes proliferation in gastric cancer cells via regulating p21 and CDK4

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Krüppel-like factors (KLFs) are crucial in various biological processes.
• While several KLFs are implicated in cancer, the role of KLF16 in gastric cancer (GC) remains largely uncharacterized.
• Understanding KLF family members' functions is vital for cancer research.

Purpose of the Study:

• To investigate the expression and functional role of KLF16 in gastric cancer (GC).
• To determine the correlation between KLF16 expression and GC clinicopathological features and prognosis.
• To explore the underlying molecular mechanisms of KLF16 in GC progression.

Main Methods:

• Immunohistochemistry (IHC) assays to assess KLF16 protein levels in GC tissues.
• Real-time quantitative PCR (qPCR) to measure KLF16 mRNA expression.
• Correlation analysis between KLF16 expression and clinicopathological parameters (tumor size, invasion depth, metastasis, TNM stage).
• Knock-down experiments in GC cell lines to evaluate the effect on proliferation, p21, and CDK4 expression.

Main Results:

• KLF16 expression was significantly upregulated in GC tissues compared to adjacent normal tissues at both protein and mRNA levels.
• Elevated KLF16 levels positively correlated with larger tumor size, deeper invasion, lymphatic metastasis, and advanced TNM stage.
• KLF16 expression served as a predictive marker for patient prognosis.
• KLF16 knock-down suppressed GC cell proliferation by increasing p21 and decreasing CDK4 expression.

Conclusions:

• KLF16 is significantly upregulated in gastric cancer and associated with aggressive tumor characteristics and poor prognosis.
• KLF16 promotes GC progression, potentially through regulating cell cycle-related genes like p21 and CDK4.
• KLF16 represents a promising novel therapeutic target for gastric cancer treatment.